Calendar

Weekly Recap & Major Analyst Calls, Looking Backwards & Forwards for 2019 in 10 Minutes

Somehow, the second quarter of 2019 has come to an end and the year is now half way over. It also appears that the snap-back rally after the "Sell in ...
Read Full Story »

Wedbush’s Top Biotech Picks Ahead of AACR Annual Meeting

The American Association for Cancer Research (AACR) annual meeting is scheduled for March 31 to April 3. Abstracts have been released for the companies presenting at this event, and Wedbush ...
Read Full Story »

24/7 Wall St. Weekend Review, Backward and Forward

It's the weekend, but 24/7 Wall St. wanted to show our readers, who may not be on our email list, what they may see each day and on the weekend. ...
Read Full Story »

Major 2019 Biopharma Catalysts Coming in February and March

Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

8 Earnings Warnings That Already Have Investors Spooked

The volatility throughout the fourth quarter and December was enough to rattle the nerves of most investors. And a large sell-off right at the start of 2019 spooked investors further, ...
Read Full Story »

Major Biopharma Catalysts Coming in the First Quarter of 2019

Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Major Health Care Catalysts Coming by the End of 2018

Companies in the health care sector face great risk and great reward every time they make an announcement. Drug candidates passing clinical trials, gaining regulatory approval or being canceled can ...
Read Full Story »

Canaccord Genuity’s Top Biopharma Catalysts Coming This Quarter

Companies in the health care sector face great risk and great reward every time they make an announcement. Drug candidates passing clinical trials, gaining regulatory approval or being canceled can ...
Read Full Story »

The Top 20 Must-Know Investor News Items for the Week of November 2

  This last week was a crazy end to the October selling craze being followed by a flood of stock buying this week prior to Friday's major profit taking. ...
Read Full Story »

How Wall Street Is Looking at Q3 Earnings Season, Sector by Sector

The week of October 15 to October 19 is when third-quarter earnings will fly into hyper-drive. Endless numbers of America's biggest and smallest companies communicating the most recent quarter and ...
Read Full Story »

Major Biopharma Catalysts to Watch For in October

Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

24/7 Wall St. Weekend Edition: 25-ish Things You May Have Missed but Should Not Miss Out On

It's the weekend and 24/7 Wall St. wanted to share a copy of what was sent out on Saturday morning to its thousands of email subscribers. After all, we wouldn't ...
Read Full Story »

Major Biopharma Catalysts on October’s FDA Calendar

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018

Biotechnology companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single clinical trial could either ...
Read Full Story »

Major Biopharma Catalysts on September’s FDA Calendar

Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »